385 related articles for article (PubMed ID: 29705631)
1. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
2. Metformin: a metabolic modulator.
Pietrocola F; Kroemer G
Oncotarget; 2017 Feb; 8(6):9017-9020. PubMed ID: 28122334
[TBL] [Abstract][Full Text] [Related]
3. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
4. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
5. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress.
Zhao M; Li XW; Chen Z; Hao F; Tao SX; Yu HY; Cheng R; Liu H
Med Sci Monit; 2019 Mar; 25():2186-2194. PubMed ID: 30905926
[TBL] [Abstract][Full Text] [Related]
6. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.
Banerjee J; Bruckbauer A; Zemel MB
Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392
[TBL] [Abstract][Full Text] [Related]
7. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
8. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
9. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
10. Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells.
Kim DS; Jeong SK; Kim HR; Kim DS; Chae SW; Chae HJ
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):251-7. PubMed ID: 20038265
[TBL] [Abstract][Full Text] [Related]
11. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
13. An energetic tale of AMPK-independent effects of metformin.
Miller RA; Birnbaum MJ
J Clin Invest; 2010 Jul; 120(7):2267-70. PubMed ID: 20577046
[TBL] [Abstract][Full Text] [Related]
14. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.
Rogalska A; Sliwinska A; Kasznicki J; Drzewoski J; Marczak A
Asian Pac J Cancer Prev; 2016; 17(3):993-1001. PubMed ID: 27039825
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of silk fibroin on high glucose induced insulin resistance in HepG2 cells.
Yang Q; Zhu Z; Wang L; Xia H; Mao J; Wu J; Kato K; Li H; Zhang J; Yamanaka K; An Y
Environ Toxicol Pharmacol; 2019 Jul; 69():66-71. PubMed ID: 30959417
[TBL] [Abstract][Full Text] [Related]
16. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
17. Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor.
Ueno S; Kimura T; Yamaga T; Kawada A; Ochiai T; Endou H; Sakurai H
J Pharmacol Sci; 2016 Jun; 131(2):110-7. PubMed ID: 27262901
[TBL] [Abstract][Full Text] [Related]
18. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
19. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Ben Sahra I; Le Marchand-Brustel Y; Tanti JF; Bost F
Mol Cancer Ther; 2010 May; 9(5):1092-9. PubMed ID: 20442309
[TBL] [Abstract][Full Text] [Related]
20. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]